ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 139 filers reported holding ACCELERON PHARMA INC in Q3 2016. The put-call ratio across all filers is 1.27 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $232,000 | +6.9% | 6,400 | 0.0% | 0.08% | -9.2% |
Q2 2016 | $217,000 | -30.4% | 6,400 | 0.0% | 0.09% | -1.1% |
Q4 2015 | $312,000 | -87.0% | 6,400 | -91.6% | 0.09% | -61.2% |
Q2 2015 | $2,405,000 | -20.0% | 76,000 | -3.8% | 0.23% | -20.1% |
Q1 2015 | $3,007,000 | -6.7% | 79,000 | -4.5% | 0.28% | -8.1% |
Q4 2014 | $3,222,000 | +28.1% | 82,700 | -0.6% | 0.31% | +18.8% |
Q3 2014 | $2,516,000 | -20.5% | 83,200 | -10.6% | 0.26% | -4.4% |
Q2 2014 | $3,163,000 | -1.2% | 93,100 | +0.3% | 0.27% | +4.2% |
Q1 2014 | $3,202,000 | -13.8% | 92,800 | -1.1% | 0.26% | -14.4% |
Q4 2013 | $3,714,000 | +91.0% | 93,800 | +7.2% | 0.30% | +68.5% |
Q3 2013 | $1,945,000 | – | 87,500 | – | 0.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Novo Holdings A/S | 1,103,937 | $53,563,000 | 5.39% |
GREAT POINT PARTNERS LLC | 758,000 | $36,778,000 | 5.10% |
Foresite Capital Management II, LLC | 244,756 | $11,876,000 | 4.18% |
GREAT POINT PARTNERS LLC | 552,300 | $26,798,000 | 3.71% |
Foresite Capital Management III, LLC | 278,753 | $13,525,000 | 2.91% |
QVT Financial LP | 190,977 | $9,266,000 | 2.66% |
Perceptive Advisors | 1,528,205 | $74,149,000 | 1.94% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,126,800 | $54,672,000 | 1.92% |
SECTORAL ASSET MANAGEMENT INC | 306,626 | $14,877,000 | 1.66% |
Parametrica Management Ltd | 5,645 | $274,000 | 1.30% |